mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
9e-05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0005 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.0005 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0007 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.088 |
0.003 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
lapatinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |